Gabriel Whitlingum

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Avoidant/restrictive food intake disorder and autism spectrum disorder: clinical implications for assessment and management

Fadila Farag, Annemarie Sims, Katy Strudwick et al. · Developmental Medicine & Child Neurology · 2021 · 83 citations · Full text

Medicine, Nutrition, Pediatrics +17

Visual impairment, severe visual impairment, and blindness in children in Britain (BCVIS2): a national observational study

Lucinda Teoh, Ameenat Lola Solebo, Jugnoo S. Rahi et al. · The Lancet Child & Adolescent Health · 2021 · 76 citations · Full text

Medicine, Ophthalmology, Pediatrics +16

Executive function and sleep problems in childhood epilepsy

Simone Holley, Andrea Whitney, Fenella J. Kirkham et al. · Epilepsy & Behavior · 2014 · 33 citations

Medicine, Neuroscience, Pediatrics +16